InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
17%
T+90 mean return
-24.7%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Sabzevari Helen, Chairman & CEO. Director active across 1 company, notably Precigen, INC.. Aggregated, 19 reports have been recorded. Split: 1 buy · 0 sell. Total volume traded: €37k. Activity tracked since 27 January 2023. The latest transaction was filed on 29 January 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations19 total
1,079,137 sharesCommon StockSEC:0000950103-25-006143:0
825,000 shares0Common StockSEC:0000950103-25-001481:0
1,071,429 sharesCommon StockSEC:0000950103-24-005095:0
141,587 sharesCommon StockSEC:0000950103-23-012774:0
141,587 sharesCommon StockSEC:0000950103-23-012318:0
141,587 sharesCommon StockSEC:0000950103-23-011942:0
141,587 sharesCommon StockSEC:0000950103-23-011610:0
283,173 sharesCommon StockSEC:0000950103-23-004824:0
22,857 shares@ US$1.75100.0% of flowCommon StockSEC:0000950103-23-001415:0
Ideal exit: 24 Oct 2023 (T+270)
17,665 sharesCommon StockSEC:0000950103-23-000200:0
340,909 sharesCommon StockSEC:0000950103-22-008541:0
17,667 sharesCommon StockSEC:0000950103-22-000271:0
17,667 sharesCommon StockSEC:0000950103-22-000271
9,765 sharesCommon StockSEC:0000950103-22-000138
9,765 sharesCommon StockSEC:0000950103-22-000138:0
25,000 sharesCommon StockSEC:0000950103-21-010821
25,000 sharesCommon StockSEC:0000950103-21-010821:0
97,276 sharesCommon StockSEC:0000950103-21-007276
97,276 sharesCommon StockSEC:0000950103-21-007276:0
19 of 19 declarations
About Sabzevari Helen
Helen Sabzevari is the President and CEO of PRECIGEN, INC. She leads the company's strategic initiatives and oversees the development of innovative solutions in the biopharmaceutical sector. Her leadership focuses on improving health outcomes and expanding the company's capabilities.
